SI0871616T1 - Process for the preparation of anti-malarial drugs - Google Patents
Process for the preparation of anti-malarial drugsInfo
- Publication number
- SI0871616T1 SI0871616T1 SI9630461T SI9630461T SI0871616T1 SI 0871616 T1 SI0871616 T1 SI 0871616T1 SI 9630461 T SI9630461 T SI 9630461T SI 9630461 T SI9630461 T SI 9630461T SI 0871616 T1 SI0871616 T1 SI 0871616T1
- Authority
- SI
- Slovenia
- Prior art keywords
- preparation
- malarial drugs
- malarial
- drugs
- Prior art date
Links
- 239000003430 antimalarial agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9521004.3A GB9521004D0 (en) | 1995-10-13 | 1995-10-13 | Process |
| EP96934646A EP0871616B1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
| PCT/EP1996/004433 WO1997013753A1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0871616T1 true SI0871616T1 (en) | 2002-12-31 |
Family
ID=10782264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9630461T SI0871616T1 (en) | 1995-10-13 | 1996-10-11 | Process for the preparation of anti-malarial drugs |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6479660B1 (cs) |
| EP (1) | EP0871616B1 (cs) |
| JP (1) | JP4083803B2 (cs) |
| KR (1) | KR100453256B1 (cs) |
| CN (1) | CN1147475C (cs) |
| AR (1) | AR004015A1 (cs) |
| AT (1) | ATE214372T1 (cs) |
| AU (1) | AU709333B2 (cs) |
| BR (1) | BR9611010A (cs) |
| CA (1) | CA2231633C (cs) |
| CZ (1) | CZ290380B6 (cs) |
| DE (1) | DE69619863T2 (cs) |
| DK (1) | DK0871616T3 (cs) |
| ES (1) | ES2170874T3 (cs) |
| GB (1) | GB9521004D0 (cs) |
| HU (1) | HUP9900739A3 (cs) |
| IL (1) | IL124060A (cs) |
| NO (1) | NO313285B1 (cs) |
| NZ (1) | NZ320209A (cs) |
| PL (1) | PL186055B1 (cs) |
| PT (1) | PT871616E (cs) |
| SA (1) | SA97170574B1 (cs) |
| SI (1) | SI0871616T1 (cs) |
| TR (1) | TR199800637T2 (cs) |
| TW (1) | TW450950B (cs) |
| WO (1) | WO1997013753A1 (cs) |
| ZA (1) | ZA968550B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08276712A (ja) * | 1995-04-05 | 1996-10-22 | Masao Tsuji | チュ−ブレススパイクタイヤ |
| GB0210150D0 (en) | 2002-05-03 | 2002-06-12 | Smithkline Beecham Plc | Process |
| PL1924558T3 (pl) * | 2005-09-12 | 2010-07-30 | Council Scient Ind Res | Przeciwmalaryczne addukty Baylisa Hillmana oraz proces ich wywarzania |
| WO2007127930A2 (en) * | 2006-04-28 | 2007-11-08 | Kansas State University Research Foundation | Compounds affecting gap junction activity |
| GB0620005D0 (en) | 2006-10-10 | 2006-11-22 | Glaxo Group Ltd | Compounds |
| US20090076072A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched tafenoquine |
| ES2453206B1 (es) | 2013-09-25 | 2015-01-12 | Thyssenkrupp Elevator Innovation Center, S.A. | Sistema de tracción para un sistema de transporte |
| CN113248431A (zh) * | 2021-05-21 | 2021-08-13 | 重庆医药高等专科学校 | 一种磷酸伯氨喹的制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431807A (en) * | 1980-06-12 | 1984-02-14 | The United States Of America As Represented By The Secretary Of The Army | 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines |
| US4617394A (en) | 1985-10-15 | 1986-10-14 | The United States Of America As Represented By The Secretary Of The Army | 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines |
-
1995
- 1995-10-13 GB GBGB9521004.3A patent/GB9521004D0/en active Pending
-
1996
- 1996-10-10 ZA ZA9608550A patent/ZA968550B/xx unknown
- 1996-10-11 PT PT96934646T patent/PT871616E/pt unknown
- 1996-10-11 BR BR9611010A patent/BR9611010A/pt not_active Application Discontinuation
- 1996-10-11 DK DK96934646T patent/DK0871616T3/da active
- 1996-10-11 US US09/051,571 patent/US6479660B1/en not_active Expired - Fee Related
- 1996-10-11 TR TR1998/00637T patent/TR199800637T2/xx unknown
- 1996-10-11 JP JP51471997A patent/JP4083803B2/ja not_active Expired - Fee Related
- 1996-10-11 HU HU9900739A patent/HUP9900739A3/hu unknown
- 1996-10-11 CZ CZ19981103A patent/CZ290380B6/cs not_active IP Right Cessation
- 1996-10-11 PL PL96326194A patent/PL186055B1/pl not_active IP Right Cessation
- 1996-10-11 WO PCT/EP1996/004433 patent/WO1997013753A1/en active IP Right Grant
- 1996-10-11 NZ NZ320209A patent/NZ320209A/xx not_active IP Right Cessation
- 1996-10-11 DE DE69619863T patent/DE69619863T2/de not_active Expired - Lifetime
- 1996-10-11 KR KR10-1998-0702696A patent/KR100453256B1/ko not_active Expired - Fee Related
- 1996-10-11 AR ARP960104723A patent/AR004015A1/es active IP Right Grant
- 1996-10-11 ES ES96934646T patent/ES2170874T3/es not_active Expired - Lifetime
- 1996-10-11 IL IL12406096A patent/IL124060A/xx not_active IP Right Cessation
- 1996-10-11 SI SI9630461T patent/SI0871616T1/xx unknown
- 1996-10-11 CA CA002231633A patent/CA2231633C/en not_active Expired - Fee Related
- 1996-10-11 EP EP96934646A patent/EP0871616B1/en not_active Expired - Lifetime
- 1996-10-11 AU AU72910/96A patent/AU709333B2/en not_active Ceased
- 1996-10-11 AT AT96934646T patent/ATE214372T1/de not_active IP Right Cessation
- 1996-10-11 CN CNB961975644A patent/CN1147475C/zh not_active Expired - Fee Related
- 1996-10-14 TW TW085112489A patent/TW450950B/zh active
-
1997
- 1997-01-20 SA SA97170574A patent/SA97170574B1/ar unknown
-
1998
- 1998-04-03 NO NO19981537A patent/NO313285B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL117188A0 (en) | Process for the preparation of thietanones | |
| HU9602957D0 (en) | Process for the preparation of dihaloazolopyrimidines | |
| IL124768A0 (en) | Novel pyridine compounds processes for their preparation and their use as pharmaceutical agents | |
| SI0877738T1 (en) | Process for the preparation of phenylimidazolidine derivatives | |
| HUP9903481A3 (en) | Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives | |
| SI0871616T1 (en) | Process for the preparation of anti-malarial drugs | |
| ZA962538B (en) | Process for the preparation of dihydroartemisinin hemisucinate | |
| IL118200A0 (en) | Process for the preparation of substituted 2-fluoro-pyrimidines | |
| ZA961050B (en) | Substituted benzenesulfonylureas and -thioureas processes for their preparation their use for the production of pharmaceutical preparations and pharmaceutical preparations containing them | |
| HRP960357B1 (en) | Process for the preparation of lovastatin | |
| IL115090A0 (en) | Process for the preparation of p-bromofluorobenzene | |
| IL118973A0 (en) | Process for the preparation of substituted aminocarbonyltriazolinones | |
| AU6738496A (en) | Process for preparing solid dosage forms of very low-dose drugs | |
| ZA963102B (en) | Process for the preparation of streptogramins | |
| ZA965515B (en) | Process for the preparation of 3-hydroxyoxetanes | |
| HUP9601325A2 (en) | Process for the preparation of optionally 2-substituted 5-chloroimidazole-4-carbaldehyde derivatives | |
| HUP9901543A3 (en) | Process for the preparation of hydroxysulfone derivatives | |
| IL118732A0 (en) | Process for the preparation of arylidene-substituted alkylcycloalkanones | |
| EP0752419A3 (de) | Verfahren zur Herstellung von N-substituierten 4-Ketoprolin-Derivaten | |
| ZA965895B (en) | Process for the preparation of alpha omega-bromochloro-alkanes | |
| ZA96338B (en) | Process for the preparation of (1-hydroxycyclohexane)- acetonitrile | |
| IL117065A0 (en) | Process for the preparation of fluorocyclopropane derivatives | |
| IL148253A0 (en) | Process for the preparation of 4-sulfanylpyrrolidin-2-yl | |
| ZA969296B (en) | New process for the preparation of morphinans | |
| HK1010842A (en) | Process for preparing solid dosage forms of very low-dose drugs |